Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

Background Over 200 clinical trials have examined the effect of eicosapentaenoic acid ( EPA ) and docosahexaenoic acid ( DHA ) supplements on risk factors associated with cardiovascular disease. However, an updated analysis of the evidence is lacking. The aim of the present meta‐analysis was to q…